Truist slashes price target on Dexcom Inc [DXCM] – find out why.

NFLX Stock

Dexcom Inc [NASDAQ: DXCM] slipped around -0.82 points on Wednesday, while shares priced at $81.01 at the close of the session, down -1.00%.

Compared to the average trading volume of 3.97M shares, DXCM reached a trading volume of 4738192 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Dexcom Inc [DXCM]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $100.36 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.47. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Truist have made an estimate for Dexcom Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 16, 2025. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on May 30, 2025, representing the official price target for Dexcom Inc stock. Previously, the target price had yet another raise to $85, while Mizuho analysts kept a Outperform rating on DXCM stock. On February 03, 2025, analysts increased their price target for DXCM shares from 85 to 115.

The Average True Range (ATR) for Dexcom Inc is set at 2.16, with the Price to Sales ratio for DXCM stock in the period of the last 12 months amounting to 7.66. The Price to Book ratio for the last quarter was 14.01, with the Price to Cash per share for the same quarter was set at 6.89. Price to Free Cash Flow for DXCM in the course of the last twelve months was 55.22 with Quick ratio for the last quarter at 1.32.

How has DXCM stock performed recently?

Dexcom Inc [DXCM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.39. With this latest performance, DXCM shares dropped by -6.84% in over the last four-week period, additionally plugging by 4.95% over the last 6 months – not to mention a drop of -30.13% in the past year of trading.

Dexcom Inc [DXCM]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Dexcom Inc [DXCM] shares currently have an operating margin of 15.25% and a Gross Margin at 59.43%. Dexcom Inc’s Net Margin is presently recorded at 12.90%.

Return on Equity for this stock inclined to 8.09%, with Return on Assets sitting at 8.09%.

Earnings analysis for Dexcom Inc [DXCM]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dexcom Inc go to 24.02%.

Insider trade positions for Dexcom Inc [DXCM]

There are presently around $97.28%, or 97.70%% of DXCM stock, in the hands of institutional investors. The top three institutional holders of DXCM stocks are: VANGUARD GROUP INC with ownership of 46.51 million shares, which is approximately 11.6516%. BLACKROCK INC., holding 34.52 million shares of the stock with an approximate value of $$3.91 billion in DXCM stocks shares; and BLACKROCK INC., currently with $$1.85 billion in DXCM stock with ownership which is approximately 4.0853%.

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.